Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

General Medicine

Clinical Pharmacology

Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: The HEP-COVID randomized clinical trial

JAMA | Oct 13, 2021 Clinical Pharmacology

Factors affecting doses of roxadustat vs darbepoetin alfa for anemia in nondialysis patients

American Journal of Nephrology | Oct 13, 2021 Clinical Pharmacology

Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: A pooled analysis of six phase 3 clinical trials

Annals of Rheumatic Diseases | Oct 09, 2021 Clinical Pharmacology

Effects of tirzepatide, a dual GIP and GLP-1 RA, on lipid and metabolite profiles in individuals with type 2 diabetes

Journal of Clinical Endocrinology and Metabolism | Oct 08, 2021 Clinical Pharmacology

Oral rilzabrutinib as a treatment for patients with pemphigus vulgaris

British Journal of Dermatology | Oct 08, 2021 Clinical Pharmacology

Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss

Diabetes, Obesity and Metabolism | Oct 08, 2021 Clinical Pharmacology

Serum potassium and mortality in high-risk patients: SPRINT

Hypertension | Oct 07, 2021 Clinical Pharmacology

Major adverse limb events in type 2 diabetes patients receiving glucagon-like peptide-1 receptor agonists vs sodium-glucose cotransporter 2 inhibitors: A retrospective multi-institutional study

Diabetes Research and Clinical Practice | Oct 07, 2021 Clinical Pharmacology

Evaluation of apremilast, an oral phosphodiesterase 4 inhibitor, for refractory cutaneous dermatomyositis: A phase 1b clinical trial

The Journal of Dermatology | Oct 07, 2021 Clinical Pharmacology

Ultra rapid lispro shows faster pharmacokinetics and reduces postprandial glucose excursions vs Humalog in patients with type 2 diabetes mellitus in a randomized, controlled cross‐over meal test early phase study

Diabetes, Obesity and Metabolism | Oct 07, 2021 Clinical Pharmacology

« Prev 1 … 30 31 32 33 34 … 338 Next »

Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: The HEP-COVID randomized clinical trial

Factors affecting doses of roxadustat vs darbepoetin alfa for anemia in nondialysis patients

Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: A pooled analysis of six phase 3 clinical trials

Effects of tirzepatide, a dual GIP and GLP-1 RA, on lipid and metabolite profiles in individuals with type 2 diabetes

Oral rilzabrutinib as a treatment for patients with pemphigus vulgaris

Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss

Serum potassium and mortality in high-risk patients: SPRINT

Major adverse limb events in type 2 diabetes patients receiving glucagon-like peptide-1 receptor agonists vs sodium-glucose cotransporter 2 inhibitors: A retrospective multi-institutional study

Evaluation of apremilast, an oral phosphodiesterase 4 inhibitor, for refractory cutaneous dermatomyositis: A phase 1b clinical trial

Ultra rapid lispro shows faster pharmacokinetics and reduces postprandial glucose excursions vs Humalog in patients with type 2 diabetes mellitus in a randomized, controlled cross‐over meal test early phase study

Alternative Therapies and Infection Management

Age Related Macular Degeneration

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Recent Advances in Storage Media for Avulsed Tooth

MIP: Nutrition and Pharmacology: Interactions, Side Effects, and Patient Education

Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: The HEP-COVID randomized clinical trial

Factors affecting doses of roxadustat vs darbepoetin alfa for anemia in nondialysis patients

Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: A pooled analysis of six phase 3 clinical trials

Effects of tirzepatide, a dual GIP and GLP-1 RA, on lipid and metabolite profiles in individuals with type 2 diabetes

Oral rilzabrutinib as a treatment for patients with pemphigus vulgaris

Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss

Serum potassium and mortality in high-risk patients: SPRINT

Major adverse limb events in type 2 diabetes patients receiving glucagon-like peptide-1 receptor agonists vs sodium-glucose cotransporter 2 inhibitors: A retrospective multi-institutional study

Evaluation of apremilast, an oral phosphodiesterase 4 inhibitor, for refractory cutaneous dermatomyositis: A phase 1b clinical trial

Ultra rapid lispro shows faster pharmacokinetics and reduces postprandial glucose excursions vs Humalog in patients with type 2 diabetes mellitus in a randomized, controlled cross‐over meal test early phase study

Alternative Therapies and Infection Management

Age Related Macular Degeneration

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Recent Advances in Storage Media for Avulsed Tooth

MIP: Nutrition and Pharmacology: Interactions, Side Effects, and Patient Education

Select Specialty

Select Topic